Raaj Medisafe India Limited will convene its Board of Directors meeting on August 12, 2026, to approve the company’s unaudited financial results for the quarter ended June 30, 2026. The meeting, scheduled for 3:00 P.M. at the company’s registered office in Ujjain, marks the formal review of Q1FY27 performance alongside key administrative appointments. Investors should note that while the financial figures will be finalized during this session, the immediate news value lies in the confirmation of the quarterly reporting timeline and the strategic hiring of a Chief Financial Officer.

The primary objective of the gathering is to consider and appoint a Chief Financial Officer, a move that signals organizational restructuring or succession planning within the finance function. Alongside this appointment, the Board will review the Limited Review Report issued by the Statutory Auditor for the same period. This dual focus on leadership appointment and financial verification ensures that the reported numbers for the quarter are subject to both internal executive oversight and external statutory validation before public dissemination.

Key Agenda Items

The Board’s agenda extends beyond financial approvals to include critical corporate governance and shareholder engagement activities. A detailed breakdown of the scheduled business is provided below:

Preparations for the 41st Annual General Meeting (AGM) constitute a significant portion of the meeting’s workload. The Board will decide the date and time for the AGM, which is planned to be held through Video Conferencing or Other Audio-Visual Means (OAVM). To facilitate this, the directors will fix the cutoff date for eligibility to participate in E-voting and appoint a scrutinizer for the E-voting process. Additionally, the Board will approve the Notice calling the 41st AGM and authorize personnel to sign and issue it.

Compliance and regulatory reporting remain central to the meeting’s proceedings. The Board will take on record the Secretarial Audit Report for the year ended March 31, 2026, issued by M/s M.Maheshwari & Associates, Practicing Company Secretaries. Furthermore, the directors will approve the Directors’ Report and Corporate Governance Report for the fiscal year ended March 31, 2026. These documents are essential for maintaining transparency with regulators and shareholders regarding the company’s governance standards and operational conduct over the past year.

Regulatory Disclosures and Compliance

In adherence to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board will also take on record several reports submitted to the Bombay Stock Exchange (BSE) for the quarter ended June 30, 2026. These include the Statement of Investors’ Complaints, the Shareholding Pattern, the Integrated Corporate Governance Report, and the Statement of Variation of Utilization of Funds raised on March 26, 2026, through Preferential Allotment of Equity Shares. The Board will also adopt the Reconciliation of Share Capital Audit Report for the quarter and review related party transactions entered into during the period. This comprehensive compliance schedule ensures that Raaj Medisafe India Limited meets all statutory disclosure requirements promptly.

Raaj Medisafe India Limited has accepted the resignation of Mrs. Kaniye Fatema Dadani Patel from the position of Chief Financial Officer (CFO) and Key Managerial Personnel (KMP). Her resignation is effective from the close of business hours on July 14, 2026. The executive stepped down to pursue new professional opportunities and for personal reasons.

The company informed the Bombay Stock Exchange of the development via a filing dated July 10, 2026. The intimation was made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The detailed disclosure regarding the change was submitted in accordance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.

Resignation Details

The following table outlines the key particulars of the resignation as disclosed by the company:

In her resignation letter addressed to the Board of Directors, Patel expressed gratitude for the support received during her tenure. She committed to ensuring a smooth transition and extending necessary assistance during the handover process. The resignation was accepted by the Managing Director, Arpit Bangur, who noted that the outgoing CFO may be required to extend support beyond July 14 to facilitate the transition.